Prot# CpG-C010: A Phase II, Open Label, Multi-Center, Single Arm, Two-Stage Study for the Evaluation of CpG 7909 in Patients with Stage IV Renal Cell Carcinoma

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date3/19/023/19/06

    Funding

    • Coley Pharmaceutical Group, Inc. (CpG-C010)